Biolase Expects Big Jump in First-Quarter Sales

Biolase Technology Inc., a medical and dental technology products company, said Thursday that it expects first-quarter sales to rise at least 75% from a year ago and doesn’t expect the economic slowdown to hurt overall growth.

The San Clemente company had sales of $1.5 million in last year’s first three months and a net loss of $1 million, or 6 cents a share.

Biolase said in a press release that two new dental lasers, in particular, are being well-received by the market, helping to boost sales this year.

The company’s stock gained 47 cents Thursday to close at $2.03 a share on Nasdaq’s small-cap market.